Should You Buy Bitcoin in 2024? [Expert's Shocking Answer]
Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.
Financials
| Curr Year EPS Estimate | -1.68 |
| Next Quarter EPS Estimate | -0.63 |
| Profit Margin | -1.24 |
| Return on Assets | -0.24 |
| Return on Equity | -0.49 |
| Revenue | 104,883,000 |
| Earnings Per Share | -2.47 |
| Revenue Per Share | 2 |
| Gross Profit | -88,318,000 |
| Quarterly Revenue Growth | 1.09 |
General
| Name | MacroGenics, Inc |
| Ticker | MGNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 370 |
About MacroGenics, Inc
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase II/III clinical trial for the treatment of breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; Enoblituzumab, a monoclonal antibody that targets B7-H3; and Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3. In addition, it is developing MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company's non-immuno-oncology clinical product candidates include MGD014, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. MacroGenics, Inc. has strategic collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
Earnings
Deere Q2 results top Street but it cuts 2024 profit outlook again as farmers buy fewer tractors
Deere's fiscal second-quarter results beat Wall Street's expectations, but the company lowered its full-year profit forecast for a second time as farmers buy fewer tractors and other equipment as they deal with declining prices for their crops.
Tim Cook Hyped 'Thinnest Apple Product Ever' At Recent iPad Event, But Cupertino's Newest Gadget Flunks Durability Test In 'Catastrophic Failure'
Apple's latest iPad Pro, with its thin design, has been the subject of discussion in the tech community since its launch earlier in May.
Must-See: Elon's New Invention is Absolutely Insane - Ad
When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing.
Amid Nvidia Craze, Jim Cramer Sees A Chip Stock 'Not On Anyone's Radar' About To Break Out: Here's What He Said
Despite it not being on anyone's radar, Jim Cramer believes that Broadcom is about to break out.
Why Is Pixelworks Stock Diving Premarket Wednesday?
Pixelworks reported Q1 results with revenue up 61% and cash at $46.2m. The CEO noted new partnerships and plans to expand their mobile business.
The Man Who Bought Bitcoin at $5 Reveals His Next Tiny Crypto Gem for 2024 - Ad
Early Bitcoin Millionaire Charlie Shrem just revealed his five little-known crypto coins that he believes could create generational wealth over the next 12 months. What's more, some of these tiny cryptos he's discovered trade for less than $1!
Ten federal agencies receive 'A+' in annual scorecard measuring small business contracting goals
NEW YORK (AP) — Federal grants can be a huge boost for small businesses. And some federal agencies do better at giving grants to small businesses than others.
Wholesale price increases accelerated in April as inflation remains sticky
WASHINGTON (AP) — U.S. wholesale prices rose sharply last month, a sign that inflation pressures remain stubbornly high after three elevated readings in consumer prices to start the year.
America Just Hit a Grim Milestone - Ad
Nearly half of U.S. households currently hold no retirement savings. Retirement expert Dr. David Eifrig says what happens next will separate a small number of winners from a very large number of losers. Learn how to protect yourself and your money with his four simple steps that he shares right here.
Elon Musk's Tesla Faces FSD Uptake Challenge As Only 2% Of Free Trial Users Subscribe, Gary Black Terms The Figure 'Disappointing'
Gary Black, a prominent figure at Future Fund, has raised concerns over the low uptake of Tesla's Full Self-Driving subscription service. Only 2% of the free trial users have opted for the subscription, a figure that is below expectations.
Tesla CEO Elon Musk Says China Is 'Awesome' After Biden Escalates EV Tariff Battle: 'Those Who Have Not Visited Have No Idea'
The billionaire CEO was responding to a Tesla enthusiast who mocked the irony of the U.S. relying on China for manufacturing but also increasing tariffs on China-made EVs.
Uranium Prices Soar 74% in 6 Months! The Uranium Bull Market Is Here to Stay! - Ad
In December 2023, 22 countries pledged to 3X their nuclear capacity. Sending these uranium stocks into a frenzy.
Joe Manchin Expresses Disappointment In Congress' Inaction Over Nation's Rising $35 Trillion Debt: 'It's A Shame ... No One Cares About It'
The initiative for a bipartisan commission to address the United States' escalating $34.6 trillion debt appears to be stalling in Congress. What Happened
Trump Meets With DeSantis, Noem Stirs Up Controversy: How Will Republican Vice President Betting Odds Be Impacted?
The relationship between Donald Trump and Ron DeSantis was heated at times during the Republican primary season, before the Florida governor dropped out of the 2024 presidential election and threw his support behind the
"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." - Ad
The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."
GOP Lawmakers In Ohio Finally Approve Rules Allowing Cannabis Sales To Begin In June, Existing Medical Marijuana Dispensaries Can Join In
Ohio lawmakers clear rules for medical and recreational marijuana programs, allowing existing retailers to apply for dual-use dispensary licenses.
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Investors See "All-Hands-On-Deck" Signal for AI - Ad
With an AI gold rush sweeping the globe, the world's richest men are piling in. Tech magnates like Bill Gates, Jeff Bezos, and Mark Zuckerberg have been spending billions to keep up with the AI boom. The tech companies themselves are one a buying spree of young companies with the next generation of AI technology.
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf Holdings, Inc. (OTC: CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024.
Elon Musk Causes Stir With Response To Professor's Ominous Prediction Of Civil War 'Coming To The West'
Elon Musk raised eyebrows with his recent tweet affirming a prediction of a civil war in the West.
22 Countries Pledge To 3X Nuclear Power - Uranium Prices Soar 74% - Ad
Newswire says "Bull market continues in Uranium stocks." Who to pick? Well, exploration records show...
Once Vehicles For Republican Presidents To Connect With Southern Whites, Motor Sports Are Shifting Away From Trump
The fading sway of Trump in motor sports suggests the breakup of the conservative-racing connection, as shown by recent developments at the Miami Grand Prix.
Elon Musk Issues Stark Warning Amid Rising National Debt: '...The Dollar Will Be Worth Nothing'
Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis.
Mystery of the Rich and Connected Revealed - Ad
Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.
Psychedelics Surpass Cannabis With Unprecedented Bipartisan Support In Congress, Says Top VA Official
Speaking at a Horizons psychedelics conference, VA Under Secretary for Health Shereef Elnahal shared insights on psychedelic medicine
Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
READ THIS If You Missed Out on the AI Boom - Ad
Radical new biotechnology predicted to grow 320,000% in 3 years. Nvidia's CEO calls it "the next amazing revolution." And one small company poised to dominate this revolution trades for just $10.
Trump Unphased By Gag Order, Fines: 'Our Constitution Is Far More Important Than Jail'
Donald Trump has been fined $10,000 for violating a gag order 10 times. The former president said he will keep speaking out.
The SEC charges Trump Media's newly hired auditing firm with 'massive fraud'
SAN FRANCISCO (AP) — The Securities and Exchange Commission on Friday charged an auditing firm hired by Trump Media and Technology Group just 37 days ago with “massive fraud” — though not for any work it performed for former President Donald Trump’s media company.
Discover "U.S.'s New Money" Before Biden Wins - Ad
A new form of money has emerged in America, and it's making some folks wildly rich... (Musk and Bezos both use it). Find out how you can too in this free video.
Bitcoin Tops Returns In All Asset Classes Amid 'Repeatedly Disappointing Inflation Data': Mohamed El-Erian Shares Insights On Market Volatility
Renowned economist Mohamed El-Erian shared a comprehensive table of financial returns for major assets and asset classes, highlighting the volatility of the market in April.
Paramount Explores Partnership Expansion With Amazon: Report
Paramount Global is reportedly discussing a potential media partnership expansion with Amazon, focusing on bundling channel sales and advertising. Paramount+, already featured on Amazon's Channels store, could see enhanced integration. Concurrently, Paramount is evaluating acquisition proposals from David Ellison and Apollo Global Management.
Buy This A.I. Stock Before Elon's "A.I. Day" on May 16 - Ad
Luke Lango is now recommending this little-known A.I. stock because it could supply Elon Musk with a critical piece of infrastructure for his new A.I. venture, something Luke is calling "Elon's A.I. 2.0". Once Elon reveals it on May 16, you may have missed the biggest gains.
Ex-DOJ Attorney Says Former Trump Aide's Testimony Sinks Ex-President's Criminal Defense: 'Big Fat Nail In The Coffin'
Trump's hush-money case has turned decidedly against him following Hope Hicks' testimony, says a legal expert.
Shell Exits Chinese Power Market, Eyes Gas Growth: Report
Shell reportedly exits China's power markets, focusing on bolstering profitability in natural gas and oil sectors. The move reflects a commitment to invest selectively in profitable ventures within the power sector, aligning with CEO Wael Sawan's vision.
Prescient CEO Makes Shocking New Prediction - Ad
Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money." Get the details before it's taken offline.
Over $20M Bet On Coupang? Check Out These 3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain.
Three groups are suing New Jersey to block an offshore wind farm
LONG BEACH TOWNSHIP, N.J. (AP) — Three anti-wind power groups are suing New Jersey to overturn a key environmental approval for a wind energy farm planned off the coast of Long Beach Island.
The Next Wave of AI Is Here - Ad
The age of artificial intelligence has been unleashed. The first wave of AI lifted the stocks of Nvidia and other companies producing chips to power AI technology. The new wave of AI has everything to do with software - and it's just getting started.
Steward Health Care says it is selling the 30+ hospitals it operates nationwide
Steward Health Care said it plans to sell off all its hospitals after announcing this week that it
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.